Get Ready to Explore with Praxis Biopharma

At Praxis Biopharma, we believe that the next generation of life-saving therapeutics will not be developed in silos, but through radical, cross-border collaboration. We provide the critical infrastructure, local regulatory intelligence, and advanced manufacturing capabilities required to transition innovative molecules from international laboratories into the Indian clinical landscape.

We act as the Authorized Strategic Partner for international biopharmaceutical and biotech firms looking to navigate the complexities of the Indian market.

• Regulatory Navigation: From SUGAM portal management to CDSCO scientific reviews, we provide a turn-key solution for international firms to secure their regulatory footprint in India.
• Clinical Site Management: Access to a network of over 1,000 accredited clinical trial sites, specialized in Non-Communicable Diseases (NCDs) and orphan drug pathways.
• Commercialization Bridge: We provide the physical and legal framework (Form 20-B/21-B) to import, store, and distribute specialized therapeutics under international quality standards.

Praxis Biopharma offers high-precision contract development and manufacturing for partners requiring advanced delivery formats.

• Novel Delivery Systems: Partner with us to leverage our pipeline in Liposomal and Orodispersible Film (ODF) technologies.
• Active Ingredient Standardization: We supply high-purity, standardized biomolecules to global B2B partners, ensuring every microgram meets stringent pharmaceutical specifications.

We are committed to the future of ethical research. Our partnership models prioritize Non-Animal Methodologies (NAMs).

• Human-Relevant Data: We collaborate with academic centers of excellence to validate therapeutic efficacy using organoids and organ-on-a-chip technologies.
• Risk Mitigation: By utilizing human-derived cellular models early in the development cycle, we help our partners identify potential clinical failures long before the human trial phase, saving millions in R&D capital.

• US-India DNA: Leadership with over 8 years of pharmaceutical experience in the United States, offering a Western standard of transparency, quality, and communication.
• GOV-Aligned Infrastructure: Our operations are designed to capitalize on India's Biopharma initiative, ensuring our partners benefit from the latest government incentives and fast-tracked regulatory cadres.
• Geographic Strategic Hub: Located in Ahmedabad, Gujarat—the pharmaceutical capital of India—providing immediate access to a world-class supply chain and talent pool.

Whether you are a clinical-stage startup or a large-scale manufacturer anywhere in the world, Praxis Biopharma is your gateway to the world's most dynamic healthcare market.